Subclinical magnesium deficiency: a principal driver of cardiovascular disease and a public health crisis
- PMID: 29387426
- PMCID: PMC5786912
- DOI: 10.1136/openhrt-2017-000668
Subclinical magnesium deficiency: a principal driver of cardiovascular disease and a public health crisis
Erratum in
-
Correction: Subclinical magnesium deficiency: a principal driver of cardiovascular disease and a public health crisis.Open Heart. 2018 Apr 5;5(1):e000668corr1. doi: 10.1136/openhrt-2017-000668corr1. eCollection 2018. Open Heart. 2018. PMID: 29634047 Free PMC article.
Abstract
Because serum magnesium does not reflect intracellular magnesium, the latter making up more than 99% of total body magnesium, most cases of magnesium deficiency are undiagnosed. Furthermore, because of chronic diseases, medications, decreases in food crop magnesium contents, and the availability of refined and processed foods, the vast majority of people in modern societies are at risk for magnesium deficiency. Certain individuals will need to supplement with magnesium in order to prevent subclinical magnesium deficiency, especially if trying to obtain an optimal magnesium status to prevent chronic disease [corrected]. Subclinical magnesium deficiency increases the risk of numerous types of cardiovascular disease, costs nations around the world an incalculable amount of healthcare costs and suffering, and should be considered a public health crisis. That an easy, cost-effective strategy exists to prevent and treat subclinical magnesium deficiency should provide an urgent call to action.
Keywords: cardiovascular disease; deficiency; magnesium; mineral.
Conflict of interest statement
Competing interests: JJD is the author of The Salt Fix and operates the website the saltfix.com.
References
-
- Martyka Z, Kotela I, Blady-Kotela A. [Clinical use of magnesium]. Przegl Lek 1996;53:155–8. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous